MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 4 (2007), Issue 10 (October)

1. Microarray based study on virulence-associated genes and resistance determinants of Staphylococcus aureus isolates from cattle.
   Vet Microbiol, 125(1): 128-40. [Abstract] [Full-text]
2. High density whole genome fingerprinting of methicillin-resistant and -susceptible strains of Staphylococcus aureus in search of phenotype-specific molecular determinants.
   J Microbiol Methods, 71(1): 44-54. [Abstract] [Full-text]
3. Clinical experience with daptomycin for the treatment of patients with osteomyelitis.
   Am J Med, 120(10): S13-20. [Abstract] [Full-text]
4. Genetic characterization of erythromycin- and methicillin-resistant community-acquired Staphylococcus aureus isolated from children in Texas.
   Diagn Microbiol Infect Dis, 59(2): 231-3. [Abstract] [Full-text]
5. In Vitro Susceptibility of Methicillin Resistant Staphylococcus aureus (MRSA) and Methicillin Susceptible Staphylococcus aureus (MSSA) to a New Antimicrobial, Copper Silicate.
   Antimicrob Agents Chemother. [Abstract] [Full-text]
6. USA300 genotype community-associated methicillin-resistant Staphylococcus aureus as a cause of surgical site infections.
   J Clin Microbiol, 45(10): 3431-3. [Abstract] [Full-text]
7. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
   J Clin Microbiol, 45(10): 3263-9. [Abstract] [Full-text]
8. Comparison of single- and multilocus sequence typing and toxin gene profiling for characterization of methicillin-resistant Staphylococcus aureus.
   J Clin Microbiol, 45(10): 3302-8. [Abstract] [Full-text]
9. A study of the efficacy and cost-effectiveness of MRSA screening and monitoring on surgical wards using a new, rapid molecular test (EMMS).
   BMC Health Serv Res, 7(1): 160. [Abstract] [Full-text]
10. Mixture of sugar and povidone-iodine stimulates healing of MRSA-infected skin ulcers on db/db mice.
    Arch Dermatol Res, 299(9): 449-56. [Abstract] [Full-text]
11. Infective endocarditis with negative blood cultures.
    Int J Antimicrob Agents, 30: S32-6. [Abstract] [Full-text]
12. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Int J Antimicrob Agents, 30(5): 398-408. [Abstract] [Full-text]
13. MRSA bacteraemia.
    Int J Antimicrob Agents, 30: S66-70. [Abstract] [Full-text]
14. CA-MRSA: The New Sports Pathogen.
    Orthop Nurs, 26(5): 310-4. [Abstract] [Full-text]
15. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
    Am J Emerg Med, 25(8): 880-6. [Abstract] [Full-text]
16. Detection of diverse SCCmec variants in methicillin-resistant Staphylococcus aureus and comparison of SCCmec typing methods.
    Clin Microbiol Infect, 13(11): 1128-30. [Abstract] [Full-text]
17. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus carriage at hospital admission.
    Infect Control Hosp Epidemiol, 28(11): 1314-7. [Abstract] [Full-text]
18. Impact of contact and droplet precautions on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus infection.
    Infect Control Hosp Epidemiol, 28(11): 1261-6. [Abstract] [Full-text]
19. Epidemiology of multidrug-resistant bacteria in patients with long hospital stays.
    Infect Control Hosp Epidemiol, 28(11): 1255-60. [Abstract] [Full-text]
20. Immunoglobulins to surface-associated biofilm immunogens provide a novel means of visualization of methicillin-resistant Staphylococcus aureus biofilms.
    Appl Environ Microbiol, 73(20): 6612-9. [Abstract] [Full-text]
21. Injection-induced pyogenic arthritis of the shoulder joint.
    J Shoulder Elbow Surg. [Abstract] [Full-text]
22. Antimicrobial therapy of Staphylococcus aureus bloodstream infection.
    Expert Opin Pharmacother, 8(15): 2505-18. [Abstract] [Full-text]
23. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA).
    J Hosp Infect, 67(2): 109-13. [Abstract] [Full-text]
24. Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination.
    J Hosp Infect, 67(2): 182-8. [Abstract] [Full-text]
25. Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany.
    J Hosp Infect, 67(2): 114-20. [Abstract] [Full-text]
26. Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial.
    Am J Infect Control, 35(8): 521-6. [Abstract] [Full-text]
27. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
    Am J Surg, 194(5): 606-10. [Abstract] [Full-text]
28. Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.
    Bioorg Med Chem Lett, 17(22): 6369-72. [Abstract] [Full-text]
29. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    BMC Infect Dis, 7: 111. [Abstract] [Full-text]
30. Design and synthesis via click chemistry of 8,9-anhydroerythromycin A 6,9-hemiketal analogues with anti-MRSA and -VRE activity.
    Bioorg Med Chem Lett, 17(22): 6340-4. [Abstract] [Full-text]
31. Synthesis, antibacterial activity, and quantitative structure-activity relationships of new (Z)-2-(nitroimidazolylmethylene)-3(2H)-benzofuranone derivatives.
    Bioorg Med Chem Lett, 17(22): 6354-63. [Abstract] [Full-text]
32. Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
    JAMA, 298(15): 1763-71. [Abstract] [Full-text]
33. A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea.
    J Antimicrob Chemother, 60(5): 1108-14. [Abstract] [Full-text]
34. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
    J Antimicrob Chemother, 60(5): 1051-9. [Abstract] [Full-text]
35. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
    Antimicrob Agents Chemother, 51(11): 3880-6. [Abstract] [Full-text]
36. randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.
    Antimicrob Agents Chemother, 51(11): 4044-8. [Abstract] [Full-text]
37. Molecular epidemiology of community-associated antimicrobial-resistant Staphylococcus aureus in Seoul, Korea (2003): pervasiveness of multidrug-resistant SCCmec type II methicillin-resistant S. aureus.
    Microb Drug Resist, 13(3): 178-85. [Abstract] [Full-text]
38. Determinants of glycopeptides consumption in hospitals.
    Microb Drug Resist, 13(3): 199-203. [Abstract] [Full-text]
39. Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.
    J Infect Dis, 196(8): 1237-47. [Abstract] [Full-text]
40. Pharmacodynamics of RWJ-54428 against Staphylococcus aureus, Streptococcus pneumoniae and Enterococcus faecalis in the Neutropenic Mouse Thigh Infection Model.
    Antimicrob Agents Chemother. [Abstract] [Full-text]
41. Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients.
    J Oral Maxillofac Surg, 65(11): 2159-63. [Abstract] [Full-text]
42. Comparison of mecA polymerase chain reaction with phenotypic methods for the detection of methicillin-resistant Staphylococcus aureus.
    Curr Microbiol, 55(6): 473-9. [Abstract] [Full-text]
43. Pseudoaneurysm following vertebral biopsy and treatment with percutaneous thrombin injection.
    Skeletal Radiol, 36(12): 1195-8. [Abstract] [Full-text]
44. Comparison of methods for the detection of methicillin resistance in Staphylococcus aureus isolates from food products.
    Lett Appl Microbiol, 45(5): 535-9. [Abstract] [Full-text]
45. Financial implications of plans to combat methicillin-resistant Staphylococcus aureus (MRSA) in an orthopaedic department.
    Ann R Coll Surg Engl, 89(7): 668-71. [Abstract] [Full-text]
46. Using marker pens on patients: a potential source of cross infection with MRSA.
    Ann R Coll Surg Engl, 89(7): 661-4. [Abstract] [Full-text]
47. Bacterial contamination of hospital bed-control handsets in a surgical setting: a potential marker of contamination of the healthcare environment.
    Ann R Coll Surg Engl, 89(7): 656-60. [Abstract] [Full-text]
48. Absolute and relative real-time PCR in the quantification of tst gene expression among methicillin-resistant Staphylococcus aureus: evaluation by two mathematical models.
    Lett Appl Microbiol, 45(5): 479-84. [Abstract] [Full-text]
49. Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from regional hospitals in Trinidad and Tobago.
    Int J Infect Dis, 11(6): 544-8. [Abstract] [Full-text]
50. Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections.
    Ann Clin Microbiol Antimicrob, 6(1): 13. [Abstract] [Full-text]

© 2004-2010 MRSA Research Today. All Rights Reserved.